These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9732033)

  • 21. Bioactive amide of prostaglandin E1 and ethanolamine plasmalogen analog of platelet-activating factor inhibits several pathways of human platelet aggregation.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 2000 Apr; 65(4):427-30. PubMed ID: 10810178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Platelet aggregation and platelet activating factor (author's transl)].
    Chignard M; Vargaftig BB; Benveniste J; Le Couedic JP
    J Pharmacol; 1980; 11(4):371-7. PubMed ID: 7206730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actions and interactions of ADP, 5- HT, histamine and PAF on equine platelets.
    Bailey SR; Andrews MJ; Elliott J; Cunningham F
    Res Vet Sci; 2000 Apr; 68(2):175-80. PubMed ID: 10756136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrastructural modifications in platelet membranes and cytoskeleton following activation.
    White JG
    Blood Cells; 1983; 9(2):237-61. PubMed ID: 6661559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of platelet-activating factor in human pathology. I. Evidence for the occurrence of basophil degranulation and release of platelet-activating factor in systemic lupus erythematosus.
    Camussi G; Tetta C; Coda R; Benveniste J
    Lab Invest; 1981 Mar; 44(3):241-51. PubMed ID: 7464048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood platelets of the African elephant.
    du Plessis L; Stevens K
    J Comp Pathol; 2002; 127(2-3):208-10. PubMed ID: 12354533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
    Elshamaa MF; Elghoroury EA; Helmy A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.
    Tsironis LD; Mitsios JV; Milionis HJ; Elisaf M; Tselepis AD
    Cardiovasc Res; 2004 Jul; 63(1):130-8. PubMed ID: 15194469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization and translocation of MMP-2 during aggregation of human platelets.
    Sawicki G; Sanders EJ; Salas E; Wozniak M; Rodrigo J; Radomski MW
    Thromb Haemost; 1998 Nov; 80(5):836-9. PubMed ID: 9843180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructure of buffalo, Syncerus caffer, platelets: comparison with bovine and human platelets.
    du Plessis L; Botha AJ; Stevens K
    J Morphol; 1996 Sep; 229(3):309-14. PubMed ID: 8765809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet granulopathy: a new morphologic feature in preleukemia and myelomonocytic leukemia: light microscopy and ultrastructural morphology and cytochemistry.
    Maldonado JE
    Mayo Clin Proc; 1976 Jul; 51(7):452-62. PubMed ID: 1064737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M; Nocun M; Watala C
    Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium.
    Yi FX; Guo ZG
    Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):379-82. PubMed ID: 10375790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia I ultrastructure.
    White JG; Nichols WL; Steensma DP
    Platelets; 2007 Jun; 18(4):273-83. PubMed ID: 17538848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ultrastructural study of the contact between type I collagen assemblies and the induced human platelet aggregates.
    Ruggiero F; Belleville J; Garrone R; Eloy R
    J Submicrosc Cytol; 1985 Jan; 17(1):11-9. PubMed ID: 3973953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets.
    Kulikov VI; Muzya GI
    Biochemistry (Mosc); 1999 Jun; 64(6):631-5. PubMed ID: 10395976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural features on the platelet response to phorbol myristate acetate.
    Estensen RD; White JG
    Am J Pathol; 1974 Mar; 74(3):441-52. PubMed ID: 4814896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.
    Bastos da Silva M; Delaunois A; Gustin P; Godeau JM; Lekeux P
    Vet Res; 2000; 31(2):267-72. PubMed ID: 10779205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet membrane ultrastructure and its changes during platelet activation.
    White JG
    Prog Clin Biol Res; 1988; 283():1-32. PubMed ID: 3062624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.